ストックスクリーナーアプリを入手
1.47
2.76%
-0.02
前日終値:
$1.45
開ける：
$1.45
24時間の取引高:
16,626
Relative Volume:
0.03
時価総額：
$5.60M
収益：
$556.00K
当期純損益:
$-5.28M
株価収益率:
-0.6869
EPS:
-2.14
ネットキャッシュフロー:
$-6.23M
1週間 パフォーマンス:
-11.88%
1か月 パフォーマンス:
-4.73%
6か月 パフォーマンス:
-52.20%
1年 パフォーマンス:
-55.80%
1日の値動き範囲:
$1.4001
$1.51
1週間の範囲:
$1.4001
$1.64
52週間の値動き範囲:
$1.28
$6.25
Cyclerion Therapeutics Inc Stock (CYCN) Company Profile
名前
Cyclerion Therapeutics Inc
セクター
電話
617-621-7722
住所
301 BINNEY STREET, CAMBRIDGE, MA
CYCN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CYCN
Cyclerion Therapeutics Inc
|
1.47 | 5.52M | 556.00K | -5.28M | -6.23M | -2.14 |
|
VRTX
Vertex Pharmaceuticals Inc
|
456.21 | 115.75B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
781.84 | 80.71B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
408.53 | 52.88B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
850.07 | 52.64B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
177.65 | 37.29B | 447.02M | -1.18B | -906.14M | -6.1812 |
Cyclerion Therapeutics Inc Stock (CYCN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2021-10-20 | 開始されました | Truist | Buy |
| 2021-09-24 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-06-03 | 開始されました | Credit Suisse | Neutral |
Cyclerion Therapeutics Inc (CYCN) 最新ニュース
Is Cyclerion Therapeutics Inc. stock a safe buy before earningsJuly 2025 Highlights & Capital Protection Trading Alerts - Улправда
Should I hold or sell Cyclerion Therapeutics Inc. stock in 20252025 Geopolitical Influence & Technical Pattern Recognition Alerts - ulpravda.ru
Will Cyclerion Therapeutics Inc. stock benefit from upcoming earnings reports2025 Fundamental Recap & Stock Portfolio Risk Management - ulpravda.ru
Will Cyclerion Therapeutics Inc. stock reach all time highs in 2025 - Улправда
Cyclerion Therapeutics (NASDAQ:CYCN) Shares Down 0.7% – Should You Sell? - Defense World
Cyclerion Therapeutics Earnings Notes - Trefis
Cyclerion Therapeutics Inc. (CYCN) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Can Cyclerion Therapeutics Inc. stock sustain institutional interestTrade Performance Summary & Safe Swing Trade Setups - Newser
Does Cyclerion Therapeutics Inc. stock trade at a discount to peersWeekly Loss Report & Verified Momentum Watchlists - Newser
How currency fluctuations impact Cyclerion Therapeutics Inc. stockJuly 2025 Sector Moves & Low Risk High Win Rate Stock Picks - Newser
Cyclerion Therapeutics (CYCN) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
Is Cyclerion Therapeutics Inc. stock attractive for growth ETFsPortfolio Risk Report & Free Long-Term Investment Growth Plans - Newser
Cyclerion Receives Milestone Payment from Akebia - TipRanks
Cyclerion Therapeutics Announces Milestone Payment from Akebia - TradingView — Track All Markets
Akebia Therapeutics, Inc. Initiates Phase 2 Clinical Trials for the Treatment of Focused Segmental Glomerulosclerosis Using Praliciguat - marketscreener.com
Cyclerion Therapeutics, Inc. Announces Revision in Its Stock Evaluation Amid Financial Trends - Markets Mojo
How strong is Cyclerion Therapeutics Inc. stock balance sheetBond Market & Real-Time Stock Movement Alerts - newser.com
Will Cyclerion Therapeutics Inc. stock maintain growth story2025 Momentum Check & Smart Swing Trading Techniques - newser.com
Smart tools for monitoring Cyclerion Therapeutics Inc.’s price actionStop Loss & Fast Gain Stock Trading Tips - newser.com
What institutional flow reveals about Cyclerion Therapeutics Inc.Quarterly Profit Report & AI Forecasted Entry and Exit Points - newser.com
Combining machine learning predictions for Cyclerion Therapeutics Inc.Weekly Stock Summary & Daily Volume Surge Signals - newser.com
Tick level data insight on Cyclerion Therapeutics Inc. volatilityRecession Risk & Trade Opportunity Analysis - newser.com
Why Cyclerion Therapeutics Inc. stock is recommended by analystsEarnings Performance Report & Fast Entry Momentum Trade Alerts - newser.com
Cyclerion Therapeutics Inc Stock Analysis and ForecastPrice-to-Book Ratio Updates & High Return Wealth Plans - earlytimes.in
What MACD and RSI say about Cyclerion Therapeutics Inc.July 2025 Retail & Risk Adjusted Swing Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock reversal real or fakeJuly 2025 Outlook & Real-Time Stock Price Movement Reports - newser.com
Live market analysis of Cyclerion Therapeutics Inc.Weekly Investment Recap & Expert Curated Trade Ideas - newser.com
Is Cyclerion Therapeutics Inc. stock a top pick in earnings seasonWeekly Stock Report & Short-Term Trading Opportunity Alerts - Fundação Cultural do Pará
Is Cyclerion Therapeutics Inc a good long term investmentLong-Term Growth Stocks & You’ve Never Seen Stock Picks Like These - earlytimes.in
Comparing Cyclerion Therapeutics Inc. in custom built stock radarsWeekly Loss Report & Reliable Price Breakout Alerts - newser.com
Cyclerion Therapeutics, Inc. SEC 10-Q Report - TradingView
Cyclerion Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
[10-Q] Cyclerion Therapeutics, Inc. Quarterly Earnings Report | CYCN SEC FilingForm 10-Q - Stock Titan
Short interest data insights for Cyclerion Therapeutics Inc.Weekly Trend Report & Fast Moving Market Watchlists - newser.com
Prepare Yourself for Liftoff: Cyclerion Therapeutics Inc (CYCN) - Setenews
Insider Stock Buying Reaches US$525.0k On Cyclerion Therapeutics - Yahoo Finance
Can Cyclerion Therapeutics Inc. stock deliver surprise earnings beatJuly 2025 Selloffs & AI Enhanced Trading Alerts - newser.com
EXCLUSIVE: Cycurion Wins $1 Million+ Contract To Modernize Federal Emergency Warning Network - Benzinga
Cyclerion Therapeutics Inc (CYCN) 財務データ
収益
当期純利益
現金流量
EPS
0.02%
3.09%
大文字化:
|
ボリューム (24 時間):